Vjregenmed

Landscape of regenerative medicine VJRegenMed 12 4 года назад
The future of CAR T-cell therapy in lymphoma VJRegenMed 13 3 года назад
The role of ARM in the cell and gene therapy industry VJRegenMed 34 2 года назад
Unmet needs in the treatment of glioblastoma VJRegenMed 28 4 года назад
Current research in regenerative medicine VJRegenMed 31 4 года назад
Gamma delta T-cell therapy VJRegenMed 56 4 года назад
The industrialization of regenerative medicine VJRegenMed 121 2 года назад
Cellular therapies: from academia to industry VJRegenMed 9 4 года назад
CMC challenges in cell and gene therapy manufacturing VJRegenMed 302 2 года назад
Future strategies in bone regeneration VJRegenMed 34 2 года назад
Limitations in the application of stem cell therapies VJRegenMed 85 4 года назад
Barriers to CAR-T for glioblastoma VJRegenMed 151 4 года назад
Future of anti-BCMA CAR T-cell therapy in myeloma VJRegenMed 17 4 года назад
Automated manufacturing in cell and gene therapy VJRegenMed 68 3 года назад
The cell therapy landscape: disruptive technologies VJRegenMed 27 3 года назад
Tocilizumab: CAR T-cell therapy in DLBCL VJRegenMed 24 4 года назад